
07/10/2025
CONGRATULATIONS!
The Portuguese pharmaceutical company Hovione has been distinguished with the Leonardo da Vinci Award 2025, an international recognition granted to outstanding family-owned enterprises. This marks the first time a Portuguese company has received the honor, which celebrates firms that combine long-term vision, innovation, and intergenerational continuity. Founded in 1959 by Ivan Villax, Hovione remains a family-run business now in its third generation, maintaining a strong commitment to research and sustainability while expanding its global reach.
Headquartered in Loures, near Lisbon, Hovione specializes in the development and manufacture of active pharmaceutical ingredients (APIs), inhalation products, and advanced drug delivery technologies. The company operates production sites in Portugal, Ireland, Macau, and the United States, employing more than 2,000 people worldwide. Hovione’s success lies in its ability to merge scientific excellence with family values, fostering innovation while preserving a culture of integrity and collaboration.
More than half of Hovione’s pharmaceutical production is exported to the United States, making it one of Portugal’s leading exporters in the sector. Despite facing import tariffs of up to 15 percent, the company continues to strengthen its transatlantic ties and invest in research and development. The international recognition highlights not only Hovione’s role as a global pharmaceutical leader but also the growing influence of Portuguese industry in the competitive field of life sciences.
More @ https://en.wikipedia.org/wiki/Hovione